Enabling access to rare disease treatment is often a challenge, especially in cost-sensitive markets such as Southeast Asia and India — but pharma companies can overcome diagnosis and funding barriers and successfully navigate the rare disease landscape. Watch this video featuring Arathi Sasidharan to learn more about access pathways for rare diseases and insights on reimbursement.
From Commitment to Reality: Overcoming the Corporate Sustainability Struggle
L.E.K. Consulting’s Inaugural Clinical and eClinical Pharma Services Survey